5-Aminobenzimidazole → HCID 178487637、化合物
反応式
FC(F)(F)C([O-])=O.[NH2:8][C:9]1[CH:17]=[CH:16][C:12]2[N:13]=[CH:14][NH:15][C:11]=2[CH:10]=1.[CH3:18][O:19][C:20]1[C:25]2[O:26][CH2:27][O:28][C:24]=2[CH:23]=[C:22]([CH:29]=O)[CH:21]=1.[Si](C#N)(C)(C)C.[N:37]1([C:42](N2C=CN=C2)=[O:43])C=CN=[CH:38]1>>[NH:13]1[C:12]2[CH:16]=[CH:17][C:9]([N:8]3[CH:29]([C:22]4[CH:21]=[C:20]([O:19][CH3:18])[C:25]5[O:26][CH2:27][O:28][C:24]=5[CH:23]=4)[CH2:38][NH:37][C:42]3=[O:43])=[CH:10][C:11]=2[N:15]=[CH:14]1参加物
6
実験手順
The compound was synthesized as trifluoroacetate salt starting from 5-aminobenzimidazole (0.585 g, 4.4 mmol), 7-methoxybenzo[d][1,3]dioxole-5-carbaldehyde (0.721 g, 4 mmol), TMSCN (0.5 mL, 4 mmol), PdC (10%, 0.02 g), TEA (0.521 mL, 3.74 mmol), di-(imidazol-1-yl)methanone (0.331 g, 2.04 mmol) as described in method 2. The product was purified by means of preparative HPLC.
後処理
- customThe product was purified by means of preparative HPLC
出典と根拠
- ORDレコード
- ord-a60c0bd07c9b4233adb9cf3e9f79c8a7
- 出典データセット
- uspto-grants-2013_07
- 特許番号
- US08486940B2
反応ノート
読み込み中…